FDX1 and liver cancer: There is a study based on ferredoxin 1 (FDX1), the key regulator of cuproptosis, and its related genes to establish a cuproptosis-related signature to evaluate the prognosis of liver cancer and guide treatment (Zhang et al. 2022a).